Key facts
- This page summarizes Donald E. Bobo Jr.'s Form 4 filing for Edwards Lifesciences Corp (EW).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 13 Jun 2022, 18:59.
Donald E. Bobo Jr. - 13 Jun 2022 Form 4 Insider Report for Edwards Lifesciences Corp (EW)
- Reporting relationship
- CVP,Strategy/Corp Development
- Issuer ticker
- EW
- Reported as of
- 13 Jun 2022
- Net transaction value
- -$368,712
- SEC form
- 4
- Accepted by SEC
- 13 Jun 2022, 18:59:48 UTC
- Prior SEC filing
- 17 May 2022
- Next SEC filing
- 08 Jul 2022
- Source filing
- View source filing
- Reporting owner signature
- Linda J. Park, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Donald E. Bobo Jr. filed Form 4 for Edwards Lifesciences Corp (EW) on 13 Jun 2022.
Change
- Previous filing in this sequence was filed on 17 May 2022.
- Current net transaction value: -$368,712.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EW
transaction
Common Stock
Options Exercise
- Transaction value
- $236,698
- Shares
- +6,725
- Change %
- +11%
- Price
- $35.20
- Shares after
- 69,286
- Date
- 13 Jun 2022
- Ownership
- Direct
- Footnotes
- F1
EW
transaction
Common Stock
Sale
- Transaction value
- $99,547
- Shares
- -1,100
- Change %
- -1.6%
- Price
- $90.50
- Shares after
- 68,186
- Date
- 13 Jun 2022
- Ownership
- Direct
- Footnotes
- F1, F2
EW
transaction
Common Stock
Sale
- Transaction value
- $505,862
- Shares
- -5,625
- Change %
- -8.2%
- Price
- $89.93
- Shares after
- 62,561
- Date
- 13 Jun 2022
- Ownership
- Direct
- Footnotes
- F1, F3
EW
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 38,267
- Date
- 13 Jun 2022
- Ownership
- 401(k)
- Footnotes
- F4
EW
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 117,320
- Date
- 13 Jun 2022
- Ownership
- By Trust
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EW
transaction
Derivative
Employee Stock Option (Right to Acquire)
Options Exercise
- Transaction value
- $0
- Shares
- -6,725
- Change %
- -9.1%
- Price
- $0.000000
- Shares after
- 67,250
- Date
- 13 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,725
- Exercise price
- $35.20
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2022.
Footnote F2
This transaction was executed in multiple trades at prices ranging from $90.32 to $90.69. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Footnote F3
This transaction was executed in multiple trades at prices ranging from $89.31 to $90.30. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Footnote F4
Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator.
SEC remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.